Last reviewed · How we verify
Ear pills
At a glance
| Generic name | Ear pills |
|---|---|
| Sponsor | Beijing University of Chinese Medicine |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effects of Auricular Point Pressing With Pellets in Children With Insufficient Hyperopia Reserve (NA)
- Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans (PHASE1, PHASE2)
- Management of Acute Tinnitus With Migraine Medications (PHASE4)
- Barotrauma in Hyperbaric Oxygen Therapy (NA)
- Biofeedback and Hydrogen Water as Treatments for Chronic Fatigue Syndrome (PHASE1)
- Observation on the Effect of Auricular Acupoint Pressing on Insomnia and Adverse Events in MHD (PHASE4)
- Breast Cancer Treatment Based on Organ-like Culture
- Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ear pills CI brief — competitive landscape report
- Ear pills updates RSS · CI watch RSS
- Beijing University of Chinese Medicine portfolio CI